Blogs

Akari Therapeutics to Present at Biotech Showcase 2024

Forex

<p>NEW YORK and BOSTON, Dec. 14, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that President and CEO Rachelle Jacques will present a company overview for in-person and virtual attendees at Biotech

Page 1287 of 9786